Zobrazeno 1 - 10
of 91
pro vyhledávání: '"David A. Barrington"'
Autor:
Monica D. Levine, Vincent M. Wagner, Courtney J. Riedinger, Wafa Khadraoui, Paulina J. Haight, Molly Morton, David A. Barrington, Corinne A. Calo, Antonio V. Castaneda, Michelle Lightfoot, Julia Chalif, Anna Gonzalez, David E. Cohn
Publikováno v:
Gynecologic Oncology Reports, Vol 52, Iss , Pp 101327- (2024)
Externí odkaz:
https://doaj.org/article/704a7afd86814abaa9dee48e07b78a35
Autor:
Corinne A. Calo, David A. Barrington, Morgan Brown, Lynette Gonzalez, Jae Baek, Allison Huffman, Jason Benedict, Floor Backes, Laura Chambers, David Cohn, Larry Copeland, Casey Cosgrove, Christa Nagel, David O'Malley, Kristin Bixel
Publikováno v:
Gynecologic Oncology Reports, Vol 42, Iss , Pp 101040- (2022)
Objective: To evaluate the association between pre-treatment neutrophil-to-lymphocyte ratio (NLR) and survival outcomes among patients with recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors. Methods: A retrospective analysis of
Externí odkaz:
https://doaj.org/article/76729e2e568f456a83fc7798ff3aa627
Autor:
Monica D. Levine, David A. Barrington, Caitlin E. Meade, Sydney M. Lammers, Eric M. McLaughlin, Adrian A. Suarez, Floor J. Backes, Larry J. Copeland, David M. O'Malley, Casey M. Cosgrove, David E. Cohn, Christa I. Nagel, Ashley S. Felix, Kristin L. Bixel
Publikováno v:
Gynecologic Oncology. 173:15-21
Autor:
Paulina J. Haight, David A. Barrington, Stephen M. Graves, Rachael N. Piver, Jae Baek, Melissa Ardizzone, Jenifer A. Akinduro, Audrey C. Busho, Deborah Fadoju, Radhika Pandit, Raeshawn Stephens, Lauren M. Strowder, Shreekari Tadepalli, Brianna VanNoy, Bhargavi Sriram, Eric M. McLaughlin, Michelle D.S. Lightfoot, Kristin L. Bixel, David E. Cohn, Casey M. Cosgrove, David O'Malley, Ritu Salani, Christa I. Nagel, Floor J. Backes
Publikováno v:
Gynecologic Oncology. 170:203-209
Publikováno v:
Applications in Plant Sciences, Vol 8, Iss 4, Pp n/a-n/a (2020)
Premise In the ferns, cell size has been explored with spores, which are largely uniform within species, produced in abundance, and durable. However, spore size and shape have been variously defined, and the relationship of these traits to genome siz
Externí odkaz:
https://doaj.org/article/c33c06c3e62146398940844a1fd54189
Publikováno v:
International Journal of Gynecologic Cancer. 32:1370-1376
BackgroundPatients in rural areas have a higher incidence of cervical cancer with increased rates of metastatic disease than their urban counterparts.ObjectiveTo evaluate whether medical provider density, acting as a surrogate for screening availabil
Publikováno v:
Gynecologic Oncology. 165:500-505
To determine the cost-effectiveness of the addition of pembrolizumab in various combinations in patients with recurrent/metastatic cervical cancer.A decision-analysis model evaluated the cost-effectiveness of chemotherapy plus pembrolizumab and bevac
Publikováno v:
Journal of Minimally Invasive Gynecology. 29:219-230
Objectives: In this study, we aim to investigate determinants of surgical approach among women with endometrial carcinoma (EC) and associations between surgical approach and overall survival (OS). Methods: The National Cancer Database (NCDB) was quer
Autor:
Kim Resnick, Paul J. Goodfellow, Sareena Singh, Steven E. Waggoner, Joseph P. McElroy, Aine Clements, Rachel Pearlman, John Nakayama, Heather Hampel, David A. Barrington, Adrian A. Suarez, Alexis Chassen, Robert Neff, Eric Jenison, Stephen Andrews, David E. Cohn, Monica Levine, Caroline C. Billingsley, Casey Cosgrove
Publikováno v:
JCO Precision Oncology. :1588-1602
PURPOSE Clinical utility of up-front multigene panel testing (MGPT) is directly related to the frequency of pathogenic variants (PVs) in the population screened and how genetic findings can be used to guide treatment decision making and cancer preven
Publikováno v:
Gynecologic oncology. 166(3)
The routine use of upfront universal germline genetic testing among patients with newly diagnosed endometrial cancer (EC) has been proposed to improve diagnosis of Lynch syndrome (LS) and discover pathogenic variants (PVs) in other cancer susceptibil